JP2019517540A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019517540A5 JP2019517540A5 JP2018563815A JP2018563815A JP2019517540A5 JP 2019517540 A5 JP2019517540 A5 JP 2019517540A5 JP 2018563815 A JP2018563815 A JP 2018563815A JP 2018563815 A JP2018563815 A JP 2018563815A JP 2019517540 A5 JP2019517540 A5 JP 2019517540A5
- Authority
- JP
- Japan
- Prior art keywords
- subject
- composition
- antibody
- administered
- body weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022129326A JP2022145965A (ja) | 2016-06-07 | 2022-08-15 | アルツハイマー病を治療する方法 |
| JP2025124966A JP2025160337A (ja) | 2016-06-07 | 2025-07-25 | アルツハイマー病を治療する方法 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662346818P | 2016-06-07 | 2016-06-07 | |
| US62/346,818 | 2016-06-07 | ||
| US201662435531P | 2016-12-16 | 2016-12-16 | |
| US62/435,531 | 2016-12-16 | ||
| PCT/EP2017/063711 WO2017211827A1 (en) | 2016-06-07 | 2017-06-06 | Methods for treating alzheimer's disease |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022129326A Division JP2022145965A (ja) | 2016-06-07 | 2022-08-15 | アルツハイマー病を治療する方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2019517540A JP2019517540A (ja) | 2019-06-24 |
| JP2019517540A5 true JP2019517540A5 (enExample) | 2020-07-09 |
Family
ID=59067640
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018563815A Withdrawn JP2019517540A (ja) | 2016-06-07 | 2017-06-06 | アルツハイマー病を治療する方法 |
| JP2022129326A Withdrawn JP2022145965A (ja) | 2016-06-07 | 2022-08-15 | アルツハイマー病を治療する方法 |
| JP2025124966A Pending JP2025160337A (ja) | 2016-06-07 | 2025-07-25 | アルツハイマー病を治療する方法 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022129326A Withdrawn JP2022145965A (ja) | 2016-06-07 | 2022-08-15 | アルツハイマー病を治療する方法 |
| JP2025124966A Pending JP2025160337A (ja) | 2016-06-07 | 2025-07-25 | アルツハイマー病を治療する方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US20200308259A1 (enExample) |
| EP (1) | EP3464350A1 (enExample) |
| JP (3) | JP2019517540A (enExample) |
| KR (2) | KR20230165883A (enExample) |
| CN (3) | CN114931635A (enExample) |
| AU (2) | AU2017276656A1 (enExample) |
| BR (1) | BR112018075300A2 (enExample) |
| CA (1) | CA3026598A1 (enExample) |
| IL (1) | IL263433B2 (enExample) |
| MA (1) | MA45149A (enExample) |
| MX (1) | MX2018015022A (enExample) |
| WO (1) | WO2017211827A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW201827467A (zh) | 2016-11-03 | 2018-08-01 | 比利時商健生藥品公司 | 焦穀胺酸類澱粉蛋白－β之抗體及其用途 |
| EP3696192A1 (en) | 2019-02-15 | 2020-08-19 | Consejo Superior De Investigaciones Científicas | Therapeutic target and monoclonal antibodies against it for the diagnosis and treatment of alzheimer´s disease |
| WO2020193644A1 (en) | 2019-03-26 | 2020-10-01 | Janssen Pharmaceutica Nv | ANTIBODIES TO PYROGLUTAMATE AMYLOID-ß AND USES THEREOF |
| CN110511276A (zh) * | 2019-08-13 | 2019-11-29 | 王跃驹 | 植物作为宿主在表达Aducanumab抗体中的应用 |
| WO2021081101A1 (en) * | 2019-10-22 | 2021-04-29 | Biogen Ma Inc. | Anti-beta-amyloid antibody for treating alzheimer's disease |
| MX2023000949A (es) | 2020-07-23 | 2023-02-22 | Othair Prothena Ltd | Anticuerpos anti-beta-amiloide (abeta). |
| KR102321601B1 (ko) * | 2020-11-19 | 2021-11-05 | 주식회사 휴런 | 뇌 영상을 이용한 알츠하이머병의 생물학적 분류 장치 및 방법 |
| TW202313111A (zh) * | 2021-06-07 | 2023-04-01 | 美商百健Ｍａ公司 | 治療阿茲海默症之方法 |
| WO2023055733A1 (en) * | 2021-09-30 | 2023-04-06 | The Scripps Research Institute | Compounds for reducing neuroinflammation |
| IL312715A (en) * | 2021-11-19 | 2024-07-01 | Ap Biosciences Inc | Bispecific Antibodies Directed to CD137 and Their Uses for Cancer Immunotherapy |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI2468770T1 (en) * | 2006-07-14 | 2018-05-31 | Ac Immune S.A. | A humanized antibody against amyloid beta. |
| EP2099826B1 (en) | 2007-01-05 | 2013-10-16 | University Of Zurich | Anti-beta-amyloid antibody and uses thereof |
| US8940272B2 (en) | 2010-10-11 | 2015-01-27 | University Of Zurich | Human anti-tau antibodies |
| KR102308915B1 (ko) * | 2012-10-15 | 2021-10-06 | 메디뮨 리미티드 | 아밀로이드 베타에 대한 항체 |
| CN105979962A (zh) * | 2012-12-07 | 2016-09-28 | 比奥根国际神经科学公司 | 使用抗Aβ抗体减少脑淀粉样蛋白斑块的方法 |
| BR112015014751A8 (pt) | 2012-12-21 | 2018-01-16 | Biogen Int Neuroscience Gmbh | anti-corpos anti-tau humanos e fragmento de ligação a tau dos mesmo, seu uso na preparação de um medicamento, bem como polipeptídeos codificando os mesmos. |
| AU2015214058B2 (en) * | 2014-02-08 | 2020-07-09 | Genentech, Inc. | Methods of treating Alzheimer's Disease |
| MA41115A (fr) * | 2014-12-02 | 2017-10-10 | Biogen Int Neuroscience Gmbh | Procédé de traitement de la maladie d'alzheimer |
-
2017
- 2017-06-06 MX MX2018015022A patent/MX2018015022A/es unknown
- 2017-06-06 CN CN202210397435.9A patent/CN114931635A/zh active Pending
- 2017-06-06 US US16/307,364 patent/US20200308259A1/en not_active Abandoned
- 2017-06-06 IL IL263433A patent/IL263433B2/en unknown
- 2017-06-06 CA CA3026598A patent/CA3026598A1/en active Pending
- 2017-06-06 JP JP2018563815A patent/JP2019517540A/ja not_active Withdrawn
- 2017-06-06 EP EP17730427.6A patent/EP3464350A1/en active Pending
- 2017-06-06 WO PCT/EP2017/063711 patent/WO2017211827A1/en not_active Ceased
- 2017-06-06 MA MA045149A patent/MA45149A/fr unknown
- 2017-06-06 CN CN202210397569.0A patent/CN114796481A/zh active Pending
- 2017-06-06 CN CN201780044190.9A patent/CN109476730A/zh active Pending
- 2017-06-06 AU AU2017276656A patent/AU2017276656A1/en not_active Abandoned
- 2017-06-06 KR KR1020237040938A patent/KR20230165883A/ko not_active Ceased
- 2017-06-06 KR KR1020197000443A patent/KR20190021311A/ko not_active Ceased
- 2017-06-06 BR BR112018075300-9A patent/BR112018075300A2/pt unknown
-
2022
- 2022-02-25 US US17/681,011 patent/US20220281963A1/en not_active Abandoned
- 2022-08-15 JP JP2022129326A patent/JP2022145965A/ja not_active Withdrawn
-
2024
- 2024-08-29 AU AU2024216442A patent/AU2024216442A1/en active Pending
-
2025
- 2025-07-25 JP JP2025124966A patent/JP2025160337A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019517540A5 (enExample) | ||
| TWI306458B (en) | Humanized antibodies that recognize beta amyloid peptide | |
| TWI890481B (zh) | 雙特異性抗體 | |
| JP2020141669A5 (enExample) | ||
| JP2020503260A5 (enExample) | ||
| JP2017511793A5 (enExample) | ||
| JP2018519810A5 (enExample) | ||
| CA2478049A1 (en) | Humanized antibodies that recognize beta amyloid peptide | |
| JP2019521647A5 (enExample) | ||
| JP2015514110A5 (enExample) | ||
| JP2018500014A5 (enExample) | ||
| HRP20231134T1 (hr) | Humanizirana i afinitetno zrela protutijela na fcrh5 i postupci za uporabu | |
| JP2022145965A (ja) | アルツハイマー病を治療する方法 | |
| JP2014114288A5 (enExample) | ||
| JP2017534646A5 (enExample) | ||
| CA2494008A1 (en) | Anti-myelin associated glycoprotein (mag) antibodies | |
| JP2020502996A5 (enExample) | ||
| RU2017120358A (ru) | Анти-il-1-бета антитела и способы их применения | |
| JP2019513726A5 (enExample) | ||
| JP2018529661A5 (enExample) | ||
| JP2021502349A5 (enExample) | ||
| JP2019532970A5 (enExample) | ||
| JP2018526330A5 (enExample) | ||
| JP2018535961A5 (enExample) | ||
| JP2020505350A5 (enExample) |